Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinfeng Chen

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Plos One|August 9, 2020
Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-LinacWilliam A Hall, Michael W Straza, Xinfeng Chen, et al.
Clinical and Translational Radiation Oncology|June 4, 2020
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experienceEric S Paulson, Ergun Ahunbay, Xinfeng Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 24, 2024
PD-1-CD28-enhanced receptor and CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumorsXinfeng Chen, Xuan Zhao, Xiaoning Mou, et al.
Experimental Cell Research|June 23, 2015
Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancerDongli Yue, Zhen Zhang, Jieyao Li, et al.
Oncology Letters|September 10, 2014
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphomaLijuan Han, Feifei Liu, Ruping Li, et al.
Cancer Biology & Medicine|March 12, 2021
L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinomaXuan Zhao, Shasha Liu, Xinfeng Chen, et al.
Scientific Reports|December 25, 2019
miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44Peng Zou, Menghai Zhu, Chong Lian, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 25, 2021
TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomasHuanyu Zhang, Guohui Qin, Chaoqi Zhang, et al.
Oncology Reports|October 30, 2014
Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacitySulan Li, Dongli Yue, Xinfeng Chen, et al.
Cancer Biology & Medicine|March 12, 2021
NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells <i>via</i> CXCL8 in esophageal squamous cell carcinomaDongli Yue, Shasha Liu, Tengfei Zhang, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Plos One|August 9, 2020
Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-LinacWilliam A Hall, Michael W Straza, Xinfeng Chen, et al.
Clinical and Translational Radiation Oncology|June 4, 2020
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experienceEric S Paulson, Ergun Ahunbay, Xinfeng Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 24, 2024
PD-1-CD28-enhanced receptor and CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumorsXinfeng Chen, Xuan Zhao, Xiaoning Mou, et al.
Experimental Cell Research|June 23, 2015
Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancerDongli Yue, Zhen Zhang, Jieyao Li, et al.
Oncology Letters|September 10, 2014
Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphomaLijuan Han, Feifei Liu, Ruping Li, et al.
Cancer Biology & Medicine|March 12, 2021
L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinomaXuan Zhao, Shasha Liu, Xinfeng Chen, et al.
Scientific Reports|December 25, 2019
miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44Peng Zou, Menghai Zhu, Chong Lian, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 25, 2021
TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomasHuanyu Zhang, Guohui Qin, Chaoqi Zhang, et al.
Oncology Reports|October 30, 2014
Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacitySulan Li, Dongli Yue, Xinfeng Chen, et al.
Cancer Biology & Medicine|March 12, 2021
NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells <i>via</i> CXCL8 in esophageal squamous cell carcinomaDongli Yue, Shasha Liu, Tengfei Zhang, et al.
Pageof 14